Novo Nordisk seeks new obesity, diabetes drugs with Replicate BioScience partnership – Reuters

Written by

admin

in

  1. Novo Nordisk seeks new obesity, diabetes drugs with Replicate BioScience partnership  Reuters
  2. Novo strikes RNA drug deal with startup Replicate  BioPharma Dive
  3. Novo Nordisk bets $550M on Replicate pact for next-gen cardiometabolic drugs  FirstWord Pharma
  4. Novo Nordisk enlists srRNA developer Replicate in $550m deal  Yahoo Finance
  5. Novo’s first obesity deal under new CEO is a $550M pact with RNA startup Replicate  Endpoints News

Continue Reading

More posts